total hip arthroplasty
Conditions
Interventions
Experimental group:Perithecal nerve block with bupivacaine liposome
Control group:Perithecal nerve block with ropivacaine
Sponsors
The First Affiliated Hospital of Guangxi Medical University
Eligibility
Sex/Gender
All
Age
40 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1. Patients undergoing unilateral THA; 2. Age 45-85 years 3. American Society of Anesthesiologists (ASA) classification i-III, NYHA classification of cardiac function i-II; 4. Body mass index (BMI) is 18-30 kg·m-2; 5. No history of Local anesthetic allergies.
Exclusion criteria
Exclusion criteria: 1. Infection at the injection site 2. Patients have severe arrhythmias or cardiovascular disease, liver and kidney dysfunction, respiratory and coagulation disorders. 3. Continue to take pain relievers in the near future. 4. Having trouble communicating and not being able to complete the scores properly. 5. I or its authorized person does not accept, can not cooperate with block patients have.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual Analog Scale (VAS) scores;quality of recovery-15 scale (QoR-15); | — |
Secondary
| Measure | Time frame |
|---|---|
| Number of PCA self-controls and total amount of medication administered;Remedial analgesic medication duration and dosage; | — |
Countries
China
Contacts
Public ContactShu Lipei
The First Affiliated Hospital of Guangxi Medical University
Outcome results
None listed